| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| Applied Materials | AMAT | 551.97 | 592.79 | 7,455,285 | +361.19 (189.32%) |
| Garrett Motion Inc. - Common Stock | GTX | 32.15 | 33.19 | 973,937 | +21.02 (188.81%) |
| NETCLASS TECHNOLOGY INC - Class A Ordinary Shares | NTCL | 4.300 | 4.620 | 47,843 | +2.81 (188.59%) |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 33.72 | 32.43 | 520,529 | +22.03 (188.45%) |
| uniQure N.V. - Ordinary Shares | QURE | 41.19 | 41.36 | 1,176,557 | +26.88 (187.81%) |
| Enerflex Ltd Common Shares | EFXT | 22.53 | 22.64 | 207,642 | +14.70 (187.74%) |
| Crinetics Pharmaceuticals, Inc. - Common Stock | CRNX | 83.50 | 42.03 | 68,364,381 | +54.44 (187.35%) |
| Immunome, Inc. - Common Stock | IMNM | 24.92 | 23.90 | 763,743 | +16.23 (186.77%) |
| Electrovaya Inc. - Common Shares | ELVA | 9.110 | 9.670 | 327,788 | +5.93 (186.48%) |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 12.70 | 12.77 | 894,605 | +8.25 (185.39%) |
| Esperion Therapeutics, Inc. - Common Stock | ESPR | 3.160 | 3.150 | 4,744,591 | +2.05 (184.68%) |
| Onto Innovation Inc. Common Stock | ONTO | 280.74 | 303.86 | 811,663 | +182.04 (184.44%) |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 6.645 | 6.380 | 1,258,222 | +4.30 (183.97%) |
| UroGen Pharma Ltd. - Ordinary Shares | URGN | 38.15 | 37.41 | 491,010 | +24.66 (182.80%) |
| InnovAge Holding Corp. - Common Stock | INNV | 11.79 | 12.11 | 164,489 | +7.62 (182.73%) |
| C4 Therapeutics, Inc. - Common Stock | CCCC | 4.270 | 4.140 | 2,562,096 | +2.75 (180.92%) |
| Sterling Infrastructure, Inc. - Common Stock | STRL | 665.60 | 717.11 | 366,321 | +428.60 (180.84%) |
| Tilly's, Inc. Common Stock | TLYS | 4.182 | 4.300 | 77,433 | +2.69 (180.67%) |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 27.46 | 26.45 | 327,347 | +17.67 (180.49%) |
| Tharimmune, Inc. - Common Stock | THAR | 4.740 | 4.740 | 0 | +3.05 (180.46%) |
| Astronics Corporation - Common Stock | ATRO | 71.30 | 71.79 | 542,382 | +45.86 (180.24%) |
| Tetra Technologies, Inc. Common Stock | TTI | 9.050 | 9.400 | 672,671 | +5.81 (179.32%) |
| Protagonist Therapeutics, Inc. - Common Stock | PTGX | 138.66 | 131.50 | 533,831 | +88.79 (178.04%) |
| Ligand Pharmaceuticals Incorporated - Common Stock | LGND | 316.11 | 320.42 | 182,815 | +202.35 (177.87%) |
| Xometry, Inc. - Class A Common Stock | XMTR | 93.37 | 94.29 | 225,000 | +59.68 (177.14%) |
| Nuvation Bio Inc. Class A Common Stock | NUVB | 5.755 | 5.600 | 4,112,858 | +3.67 (176.68%) |
| Surrozen, Inc. - Common Stock | SRZN | 23.07 | 23.66 | 109,379 | +14.72 (176.29%) |
| EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | EDAP | 4.320 | 4.320 | 0 | +2.75 (175.16%) |
| Maze Therapeutics, Inc. - Common Stock | MAZE | 33.21 | 32.35 | 230,818 | +21.09 (174.01%) |
| Kymera Therapeutics, Inc. - Common Stock | KYMR | 120.01 | 114.76 | 425,463 | +76.20 (173.93%) |